Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
White Buffalo Trading Co. is a provider of botanical supplements and alternative health products, specializing in the distribution of Kratom (Mitragyna speciosa) and CBD-based formulations. The company operates primarily as a retail and wholesale entity within the nutraceutical sector, offering various strains of plant extracts marketed for their potential analgesic and anxiolytic properties. Unlike traditional biotechnology firms, White Buffalo Trading Co. does not engage in proprietary drug discovery or clinical trial programs. Its business model is centered on the supply chain management and commercial sale of naturally derived compounds to the wellness market. The company serves a broad consumer base seeking alternative therapies for pain management and mood support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on White Buffalo Trading Co..